Salute e Benessere
Orexo AB´s sustainability work ranked among top 5% by EcoVadis
It showcases the outcome of dedicated sustainability activities undertaken over the last several years across social, environmental and governance areas of Orexo AB. And it shows how the employees and partners are working together to achieve successes across four areas: Environment, Labor and Human Rights, Ethics and Sustainable Procurement.
Nikolaj Sørensen, President and CEO, of Orexo, said,
Nikolaj Sørensen, President and CEO
Lena Wange , IR & Communications Director
ir@orexo.com
+46 (0)18 780 88 00
EcoVadis:
https://ecovadis.com/
Sustainability at Orexo:
https://orexo.com/sustainability/
Orexo is a Swedish pharmaceutical company with over 25 years of experience developing improved pharmaceuticals based on proprietary formulation technologies that meet large medical needs. On the US market, Orexo provides innovative treatment solutions for patients suffering from opioid use disorder and adjacent diseases. Products targeting other therapeutic areas are developed and commercialized worldwide with leading partners. Total net sales in 2023 amounted to SEK 639 million , and the number of employees to 116. Orexo is listed on Nasdaq Stockholm's main list and is available as an ADR on OTCQX (ORXOY) in the US.
For more information about Orexo please visit www.orexo.com . You can also follow Orexo on X, LinkedIn, and YouTube.
The information was submitted for publication at 8 a.m. CET , on July 10, 2024 .
This information was brought to you by Cision http://news.cision.com
The following files are available for download:
View original content: https://www.prnewswire.co.uk/news-releases/orexo-abs-sustainability-work-ranked-among-top-5-by-ecovadis-302193098.html